Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study

BACKGROUND/AIM: This study aimed to evaluate the efficacy of rituximab in children with difficult-to-treat nephrotic syndrome, considering the type of disease (steroid-sensitive or –resistant) and the dosing regimen. MATERIALS AND METHODS: This multicenter retrospective study enrolled children with...

Descripción completa

Detalles Bibliográficos
Autores principales: TAŞDEMİR, Mehmet, CANPOLAT, Nur, YILDIZ, Nurdan, ÖZÇELİK, Gül, BENZER, Meryem, SAYGILI, Seha Kamil, ÖZKAYIN, Emine Neşe, TÜRKKAN, Özde Nisa, BALAT, Ayşe, CANDAN, Cengiz, ÇELAKIL, Mehtap, YAVUZ, Sevgi, AKINCI, Nurver, GÖKNAR, Nilüfer, AKGÜN, Cihangir, TÜLPAR, Sebahat, ALPAY, Harika, SEVER, Fatma Lale, BİLGE, İlmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569731/
https://www.ncbi.nlm.nih.gov/pubmed/33581711
http://dx.doi.org/10.3906/sag-2012-297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569731/
https://www.ncbi.nlm.nih.gov/pubmed/33581711
http://dx.doi.org/10.3906/sag-2012-297

Ejemplares similares